A. Morin

发表

Fuzzy Tandem Repeats Containing p53 Response Elements May Define Species-Specific p53 Target Genes

F. Toledo, I. Simeonova, V. Lejour, 2012, PLoS genetics.

From Nf1 to Sdhb knockout: Successes and failures in the quest for animal models of pheochromocytoma

P. Bénit, P. Rustin, A. Morin, 2016, Molecular and Cellular Endocrinology.

Persistent Properties of a Subpopulation of Cancer Cells Overexpressing the Hedgehog Receptor Patched

C. Pasquier, A. Morin, K. Lebrigand, 2022, Pharmaceutics.

Loss of SDHB Promotes Dysregulated Iron Homeostasis, Oxidative Stress, and Sensitivity to Ascorbate

P. Bénit, E. Letouzé, A. Morin, 2021, Cancer Research.

SIRNA-Directed In Vivo Silencing of Androgen Receptor Inhibits the Growth of Castration-Resistant Prostate Carcinomas

A. Morin, C. Mauduit, M. Benahmed, 2007, PloS one.

Identification of CAD as an androgen receptor interactant and an early marker of prostate tumor recurrence

C. Gallou-Kabani, V. Firlej, L. Fritsch, 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas

Aurélie Morin, Bertrand Dousset, Aurélien de Reyniès, 2015, Nature Communications.

Testosterone regulates FGF‐2 expression during testis maturation by an IRES‐dependent translational mechanism

A. Morin, A. Prats, H. Prats, 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Rodent models of pheochromocytoma, parallels in rodent and human tumorigenesis

A. Morin, J. Favier, A. Buffet, 2018, Cell and Tissue Research.

Loss of succinate dehydrogenase activity results in dependency on pyruvate carboxylation for cellular anabolism

Christian M. Metallo, C. Ludwig, A. Morin, 2015, Nature Communications.

Thrombospondin-1 triggers cell migration and development of advanced prostate tumors.

C. Gallou-Kabani, V. Firlej, A. Morin, 2011, Cancer research.

TET-Mediated Hypermethylation Primes SDH-Deficient Cells for HIF2α-Driven Mesenchymal Transition.

E. Letouzé, A. Morin, A. Gimenez-Roqueplo, 2020, Cell reports.

Mdm4 loss in mice expressing a p53 hypomorph alters tumor spectrum without improving survival

F. Toledo, I. Simeonova, V. Lejour, 2014, Oncogene.

Dosage-dependent regulation of VAV2 expression by steroidogenic factor-1 drives adrenocortical carcinoma cell invasion

J. Bertherat, E. Lalli, M. Fassnacht, 2017, Science Signaling.

Risk of Hormone Escape in a Human Prostate Cancer Model Depends on Therapy Modalities and Can Be Reduced by Tyrosine Kinase Inhibitors

M. Poupon, A. Morin, J. Céraline, 2012, PloS one.

Systemic delivery and quantification of unformulated interfering RNAs in vivo.

C. Gallou-Kabani, A. Morin, F. Cabon, 2009, Current topics in medicinal chemistry.

Rodent models of pheochromocytoma, parallels in rodent and human tumorigenesis

A. Morin, J. Favier, A. Buffet, 2018, Cell and Tissue Research.

Oncometabolites‐driven tumorigenesis: From genetics to targeted therapy

E. Letouzé, A. Morin, A. Gimenez-Roqueplo, 2014, International journal of cancer.

In Vivo Detection of Succinate by Magnetic Resonance Spectroscopy as a Hallmark of SDHx Mutations in Paraganglioma

P. Bénit, B. Tavitian, C. Cuénod, 2015, Clinical Cancer Research.

Germline Mutations in the Mitochondrial 2-Oxoglutarate/Malate Carrier SLC25A11 Gene Confer a Predisposition to Metastatic Paragangliomas.

E. Letouzé, J. Bertherat, A. Morin, 2018, Cancer research.

Deciphering the molecular basis of invasiveness in Sdhb-deficient cells

E. Letouzé, A. Bemelmans, A. Morin, 2015, Oncotarget.

Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas.

P. Rustin, A. Morin, R. Letón, 2014, Human molecular genetics.

Establishment of a mouse xenograft model of metastatic adrenocortical carcinoma.

A. Das, E. Lalli, A. Morin, 2017, Oncotarget.

Of mice and men

F. Toledo, I. Simeonova, V. Lejour, 2013, Transcription.